Synopsis
Choose effective maternal antibiotics and analgesics while breastfeeding, state usable adult regimens, screen maternal and infant modifiers, and explain why compatible treatment rarely requires interruption of feeding.
- Treat the maternal diagnosis adequately first; unnecessary undertreatment can worsen infection, increase drug exposure through prolonged illness and threaten breastfeeding more than a compatible medicine course.
- For bacterial lactational mastitis meeting antibiotic criteria, the cited NHS Dumfries & Galloway pathway uses flucloxacillin 500 mg orally four times daily for 10–14 days.
- SPS states that penicillins can be used during breastfeeding with precautionary infant monitoring; this general advice applies to full-term healthy infants and needs specialist input for premature or unwell babies.
Key red flags
Maternal sepsis, infant apnoea or marked sedation, or a rapidly enlarging breast collection requires urgent clinical care rather than telephone reassurance about medicine compatibility.
Reasoning priorities
Identify allergies, interactions and duplicate active ingredients before prescribing.
Record reaction phenotype and all over-the-counter combination products. A brand name alone can conceal paracetamol, ibuprofen, decongestant or opioid duplication.
Worked reasoning
A stable breastfeeding patient has worsening focal mastitis after 24 hours of effective feeding support, an infected fissure, no collection and no penicillin allergy; the infant is full term and well.
- Confirm bacterial-treatment criteria, observations, absence of abscess and the exact allergy, renal, liver and interacting-medicine history.
- Use NHS Dumfries & Galloway guidance to prescribe flucloxacillin 500 mg orally four times daily for 10–14 days. Explain the empty-stomach, water and upright instructions and agree a 48-hour response review.
- Continue comfortable breastfeeding and select paracetamol or ibuprofen after dose reconciliation and maternal contraindication checks. For the flucloxacillin/paracetamol combination, assess severe renal impairment, sepsis or malnutrition and arrange the risk-based review described in prescribing.
- Advise monitoring of the infant for diarrhoea, thrush, rash and poor feeding and provide an urgent route for infant illness or maternal deterioration.
- At the 48-hour review the patient is afebrile, the erythematous area and tenderness have reduced, feeding is comfortable and no focal collection is found; the infant feeds normally without rash or diarrhoea. These observed improvements support the initial antibiotic and feeding plan, so complete the agreed course and retain return advice. Persistent fever, a new mass or deterioration would instead trigger culture, ultrasound and reassessment of diagnosis and drainage.
Key medicines
FlucloxacillinThe NHS Dumfries & Galloway adult bacterial-mastitis example is flucloxacillin 500 mg by mouth four times a day for 10–14 days. Swallow the selected 500 mg capsule with 250 mL water, at least one hour before or two hours after meals, and do not lie down immediately after taking it.Exclude flucloxacillin/product or beta-lactam hypersensitivity, including serious delayed reactions, and previous flucloxacillin-related jaundice or hepatic dysfunction. CrCl under 10 mL/min requires individual consideration of a reduced dose or extended interval before prescribing this schedule; do not add a dialysis replacement dose. Review existing hepatic disease, methotrexate, probenecid, warfarin/INR and possible loss of voriconazole effect. Flucloxacillin with paracetamol warrants particular caution in severe renal impairment, sepsis or malnutrition because of high anion gap metabolic acidosis; use the risk-conditioned monitoring and stopping advice in the paracetamol card. Higher flucloxacillin doses or additional hypokalaemia risks warrant potassium monitoring. For a healthy term breastfed infant, watch for diarrhoea, thrush, rash and feeding change.
Paracetamol500–1,000 mg orally when required, with at least four hours between doses and no more than four doses or 4 g in 24 hours for a standard adult.Avoid product hypersensitivity and concurrent duplicate paracetamol products; calculate the full 24-hour exposure, then choose one coherent regimen. Seek an individual maximum for low weight, malnutrition, chronic alcohol excess, liver or kidney impairment, and review prolonged daily use and warfarin. In a patient also receiving flucloxacillin, severe renal impairment, sepsis or glutathione depletion increases high anion gap metabolic acidosis risk, particularly with maximal or prolonged paracetamol use: review the combination and arrange close clinical/acid-base monitoring when this risk is present. Suspected pyroglutamic acidosis requires prompt paracetamol cessation and urgent assessment; urinary 5-oxoproline can help the investigating team. This is not a routine testing requirement or a prohibition of short-course coadministration in a healthy parent. Seek urgent advice after excess dosing even if initially well.